ALFA-AMYLASE BIOGARAN CONSEIL 3 000 U.CEIP, coated tablet 18 tablets
Active ingredients: ALFA-AMYLASE
Commercialized according to BDPM
Coated tablet18 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ALFA-AMYLASE BIOGARAN CONSEIL 3 000 U.CEIP, comprimé enrobé
- Pharmaceutical form
- comprimé enrobé
- Route of administration
- orale
- Presentation description
- 1 plaquette(s) thermoformée(s) PVC PVDC aluminium de 18 comprimé(s)
- Marketing authorisation holder
- BIOGARAN
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 25 Oct 2024
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63124011CIP74964404CIP133400949644049Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ALFA-AMYLASEcomprimé | 3000 unités CEIP · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.